skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Markers of inflammation predict mortality and are reduced by pexelizumab in patients with acute myocardial infarction insights from the complement inhibition in myocardial infartion treated with angiooplasty (COMMA) trial

Pierre Theroux Paul W Armstrong; Lina M Gonzales; Kenneth W Mahaffey; Judith S Hochman; Scott Rollins; Kevin J Malloy; Thomas Parish; José Carlos Nicolau; Joel Lavoie; Christopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 287A, res. 833-5, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

2
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction results from the cardinal trial

Manesh R. Patel Kenneth W Mahaffey; Paul W Amstrong; W. Douglas Weaver; Tasissa Gudaye; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Thomas H Parish; Scott Rollins; Pierre Theroux; Wiltold Ruzyllo; José Carlos Nicolau; Cristopher B Granger; Annual Scientific Session American College of Cardiology (53. 2004 New Orleans, EUA)

Journal American College of Cardiology New York v.43, suppl. A, p. 291A, res. 1118-102, 2004

New York 2004

Localização: FM - Fac. Medicina    (BCSEP 2004 65 ) e outros locais(Acessar)

3
Baseline glucose and left ventricular remodeling after acute myocardial infarction
Baseline glucose and left ventricular remodeling after acute myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline glucose and left ventricular remodeling after acute myocardial infarction

José C. Nicolau Lilia N Maia; João V Vitola; Kenneth W Mahaffey; Maurício N Machado; José A. F Ramires

Journal of Diabetes and its Complications New York v. 21, n. 5, p. 294-299, October, 2007

New York 2007

Acesso online. A biblioteca também possui exemplares impressos.

4
Baseline glucose and left ventricular remodeling after acute myocardial infarction
Baseline glucose and left ventricular remodeling after acute myocardial infarction
Material Type:
Artigo 		Adicionar ao Meu Espaço

Baseline glucose and left ventricular remodeling after acute myocardial infarction

José C. Nicolau Lilia N Maia; João V Vitola; Kenneth W Mahaffey; Maurício N Machado; José A. F Ramires

Journal of Diabetes and its Complications New York v. 21, n. 5, p. 294-299, October, 2007

New York 2007

Acesso online. A biblioteca também possui exemplares impressos.

5
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

6
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic Usefulness of White Blood Cell Count and Temperature in Acute Myocardial Infarction (from the CARDINAL Trial)

Manesh R. Patel Kenneth W Mahaffey; Paul W Armstrong; W. Douglas Weaver; Gudaye Tasissa; Judith S Hochman; Thomas G Todaro; Kevin J Malloy; Scott Rolins; Pierre Therou; Witold Ruzyllo; José Carlos Nicolau; Christopher B Granger

American Journal of Cardiology Orlando v. 95, n. 5, p. 614-618, March, 2005

Orlando 2005

Localização: FM - Fac. Medicina    (FM BCBIB )(Acessar)

7
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

8
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

9
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effect of pexelizumab, an anti-c5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardia infarction the complement inhibition in myocardial infarction treated with thrombolytics (COMPLY) trial

Kenneth W. Mahaffey Christopher B Granger; Jose C Nicolau; Witold Ruzyllo; Douglas Weaver; Pierre Theroux; Judith S Hochman; Thomas G Filloon; Christopher F Mojcik; Thomas G Todaro; Paul W Armstrong

Circulation Philadelphia v. 108, n. 10, p. 1176-1183, september 2003

Philadelphia 2003

Item não circula. Consulte sua biblioteca.(Acessar)

10
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pexelizumab, an anti-C5 complement antibody, as adjuntive therapy to primary percutaneos coronary intervention in acute myocardial infarction The COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial

Christopher B. Granger Kenneth W Mahaffey; Douglas Weaver; Pierre Theroux; Judith Hochman; Thomas G Filloon; Scott Rollins; Thomas G Todado; Witold Ruzyllo; Paul W Armstrong; José C Nicolau

Circulation, Baltimore v. 18, p. 1184-1190

Baltimore 2003

Item não circula. Consulte sua biblioteca.(Acessar)

Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1977  (24)
  2. 1977Até1988  (94)
  3. 1989Até2000  (118)
  4. 2001Até2013  (211)
  5. Após 2013  (200)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (643)
  2. Japonês  (56)
  3. Espanhol  (3)
  4. Alemão  (2)
  5. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Mahaffey, K
  2. Nicolau, J
  3. Armstrong, P
  4. Ruzyllo, W
  5. Hochman, J

Neste Assunto:

  1. Science & Technology
  2. Life Sciences & Biomedicine
  3. Humans
  4. Female
  5. Male

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.